Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients.
Scappini B, Gianfaldoni G, Caracciolo F, Mannelli F, Biagiotti C, Romani C, Pogliani EM, Simonetti F, Borin L, Fanci R, Cutini I, Longo G, Susini MC, Angelucci E, Bosi A.
Scappini B, et al. Among authors: angelucci e.
Am J Hematol. 2012 Dec;87(12):1047-51. doi: 10.1002/ajh.23308. Epub 2012 Aug 1.
Am J Hematol. 2012.
PMID: 23151979
Free article.
Clinical Trial.